To include your compound in the COVID-19 Resource Center, submit it here.

AZ, Lilly BACE inhibitor moves ahead in AD study

AstraZeneca plc (LSE:AZN; NYSE:AZN) and Eli Lilly and Co. (NYSE:LLY) said the ongoing

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE